Login to Your Account

Financings Roundup

Monday, December 10, 2012
• Northwest Biotherapeutics Inc., of Bethesda, Md., said it priced an underwritten public offering of 3 million shares of common stock, and warrants to purchase up to an aggregate 1.5 million shares of common stock, at $4 per share and $0.01 per warrant. The warrants have a per-share exercise price of $5, are exercisable immediately, and expire five years from the date of issuance.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription